$VTR
Ventas, Inc.

2023 Q4 Form 10-Q Financial Statement

#000074026023000188 Filed on November 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $1.164B $1.150B
YoY Change 10.74% 10.85%
Cost Of Revenue $669.4M $657.9M
YoY Change 13.16% 15.11%
Gross Profit $495.0M $491.9M
YoY Change 7.63% 5.62%
Gross Profit Margin 42.51% 42.78%
Selling, General & Admin $36.38M $33.30M
YoY Change 8.47% -6.0%
% of Gross Profit 7.35% 6.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $435.3M $370.4M
YoY Change 34.27% 22.85%
% of Gross Profit 87.94% 75.3%
Operating Expenses $471.7M $331.0M
YoY Change 54.68% 7.18%
Operating Profit $23.33M $160.9M
YoY Change -84.95% 2.56%
Interest Expense -$161.7M $147.9M
YoY Change 76.66% 23.87%
% of Operating Profit -693.36% 91.93%
Other Income/Expense, Net $22.31M -$9.432M
YoY Change -146.37% 2.95%
Pretax Income -$80.02M -$76.81M
YoY Change 73.94% 1415.05%
Income Tax $4.698M -$1.662M
% Of Pretax Income
Net Earnings -$90.82M -$69.56M
YoY Change 101.73% -2370.94%
Net Earnings / Revenue -7.8% -6.05%
Basic Earnings Per Share -$0.18
Diluted Earnings Per Share -$0.23 -$0.18
COMMON SHARES
Basic Shares Outstanding 402.4M shares 402.4M shares
Diluted Shares Outstanding 406.7M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $508.8M $433.9M
YoY Change 315.13% 198.97%
Cash & Equivalents $508.8M $433.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $508.8M $433.9M
YoY Change 315.13% 198.97%
LONG-TERM ASSETS
Property, Plant & Equipment $21.75B $22.09B
YoY Change 2.78% 3.81%
Goodwill $1.045B $1.045B
YoY Change 0.07% 0.12%
Intangibles
YoY Change
Long-Term Investments $598.2M $659.2M
YoY Change -11.42% 8.75%
Other Assets $112.9M $220.4M
YoY Change 9.03% 34.73%
Total Long-Term Assets $24.22B $24.53B
YoY Change 0.75% 1.56%
TOTAL ASSETS
Total Short-Term Assets $508.8M $433.9M
Total Long-Term Assets $24.22B $24.53B
Total Assets $24.73B $24.97B
YoY Change 2.35% 2.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.042B $1.090B
YoY Change 0.96% 2.45%
Accrued Expenses $312.1M $317.4M
YoY Change 3.71% 11.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.354B $1.407B
YoY Change 1.58% 4.37%
LONG-TERM LIABILITIES
Long-Term Debt $13.49B $13.39B
YoY Change 9.71% 9.64%
Other Long-Term Liabilities $9.243M $5.098M
YoY Change 42.38% -46.29%
Total Long-Term Liabilities $13.50B $13.39B
YoY Change 9.73% 9.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.354B $1.407B
Total Long-Term Liabilities $13.50B $13.39B
Total Liabilities $14.88B $14.83B
YoY Change 8.83% 8.95%
SHAREHOLDERS EQUITY
Retained Earnings -$6.214B -$5.941B
YoY Change 14.03% 13.73%
Common Stock $15.75B $15.78B
YoY Change 0.71% 0.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.76M
YoY Change 2467.91%
Treasury Stock Shares
Shareholders Equity $9.488B $9.818B
YoY Change
Total Liabilities & Shareholders Equity $24.73B $24.97B
YoY Change 2.35% 2.74%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$90.82M -$69.56M
YoY Change 101.73% -2370.94%
Depreciation, Depletion And Amortization $435.3M $370.4M
YoY Change 34.27% 22.85%
Cash From Operating Activities $279.1M $286.1M
YoY Change 4.43% -4.71%
INVESTING ACTIVITIES
Capital Expenditures $243.0M $158.9M
YoY Change 41.01% -245.98%
Acquisitions
YoY Change
Other Investing Activities $199.7M $145.1M
YoY Change 419.8% -353.78%
Cash From Investing Activities -$43.28M -$13.78M
YoY Change -67.68% -91.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -165.5M 9.791M
YoY Change 4.08% -108.74%
NET CHANGE
Cash From Operating Activities 279.1M 286.1M
Cash From Investing Activities -43.28M -13.78M
Cash From Financing Activities -165.5M 9.791M
Net Change In Cash 70.35M 282.2M
YoY Change -374.64% 1170.57%
FREE CASH FLOW
Cash From Operating Activities $279.1M $286.1M
Capital Expenditures $243.0M $158.9M
Free Cash Flow $36.09M $127.2M
YoY Change -61.99% -68.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9432000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9162000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
1226645000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
1042346000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76813000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5070000 usd
CY2023Q3 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
-5119000 usd
CY2022Q3 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
1970000 usd
CY2023Q3 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
10711000 usd
CY2022Q3 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
136000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1662000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6027000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3063000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1256000 usd
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
402381000 shares
CY2023Q3 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1472000 usd
CY2022Q3 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1750000 usd
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
4614000 usd
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
4473000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-69559000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
54419000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2453000 usd
us-gaap Profit Loss
ProfitLoss
54419000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4573000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4881000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2428000 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Profit Loss
ProfitLoss
2453000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-24427000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3371000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
41013000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13215000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
15668000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
885000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14783000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10028444000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-69559000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7184000 usd
CY2023Q3 vtr Noncontrolling Interest Period Increase Decrease Including Impact To Equity
NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity
10518000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
181671000 usd
CY2023Q3 vtr Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture
StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture
88436000 usd
CY2023Q3 vtr Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value
AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue
11785000 usd
CY2023Q3 vtr Adjustments To Equity Redemption Of Limited Partnership Units
AdjustmentsToEquityRedemptionOfLimitedPartnershipUnits
18000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9874119000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10603394000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2933000 usd
CY2022Q3 vtr Noncontrolling Interest Period Increase Decrease Including Impact To Equity
NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity
30584000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
180589000 usd
CY2022Q3 vtr Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture
StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture
5963000 usd
CY2022Q3 vtr Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value
AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue
27746000 usd
CY2022Q3 vtr Adjustments To Equity Redemption Of Limited Partnership Units
AdjustmentsToEquityRedemptionOfLimitedPartnershipUnits
-14000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10431912000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10221677000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49846000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4573000 usd
us-gaap Profit Loss
ProfitLoss
54419000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32163000 usd
vtr Noncontrolling Interest Period Increase Decrease Including Impact To Equity
NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity
20048000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.35
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
541745000 usd
vtr Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture
StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture
123852000 usd
vtr Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value
AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue
3852000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4881000 usd
vtr Noncontrolling Interest Assumed From Acquisitions
NoncontrollingInterestAssumedFromAcquisitions
0 usd
vtr Noncontrolling Interest Assumed From Acquisitions
NoncontrollingInterestAssumedFromAcquisitions
3351000 usd
vtr Settlements Of Loans Receivable
SettlementsOfLoansReceivable
486082000 usd
vtr Settlements Of Loans Receivable
SettlementsOfLoansReceivable
0 usd
vtr Settlements Of Loans Receivable Real Estate Received
SettlementsOfLoansReceivableRealEstateReceived
1566395000 usd
vtr Settlements Of Loans Receivable Real Estate Received
SettlementsOfLoansReceivableRealEstateReceived
0 usd
vtr Real Estate Owned Debt Assumed
RealEstateOwnedDebtAssumed
1016804000 usd
vtr Real Estate Owned Debt Assumed
RealEstateOwnedDebtAssumed
0 usd
vtr Investment In Unconsolidated Entities Non Cash Transaction
InvestmentInUnconsolidatedEntitiesNonCashTransaction
0 usd
vtr Investment In Unconsolidated Entities Non Cash Transaction
InvestmentInUnconsolidatedEntitiesNonCashTransaction
8100000 usd
us-gaap Nature Of Operations
NatureOfOperations
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1—DESCRIPTION OF BUSINESS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ventas, Inc. (together with its consolidated subsidiaries, unless otherwise indicated or except where the context otherwise requires, “we,” “us,” “our,” “Company” and other similar terms), an S&amp;P 500 company, is a real estate investment trust (“REIT”) operating at the intersection of healthcare and real estate. We hold a highly diversified portfolio of senior housing communities, outpatient medical buildings, research centers, hospitals and other healthcare facilities, which we generally refer to collectively as “healthcare real estate,” located throughout the United States, Canada and the United Kingdom. As of September 30, 2023, we owned or had investments in approximately 1,400 properties (including properties classified as held for sale). Our company was originally founded in 1983 and is headquartered in Chicago, Illinois with additional corporate offices in Louisville, Kentucky and New York, New York. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily invest in a diversified portfolio of healthcare real estate assets through wholly-owned subsidiaries and other co-investment entities. We operate through three reportable business segments: triple-net leased properties, senior housing operating portfolio, which we also refer to as “SHOP” and which was formerly known as senior living operations, and outpatient medical and research portfolio, which was formerly known as office operations. See “Note 2 – Accounting Policies” and “Note 15 – Segment Information.” Our senior housing communities are either subject to triple-net leases, in which case they are included in our triple-net leased properties reportable business segment, or operated by third-party managers, in which case they are included in our SHOP reportable business segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, we leased a total of 335 properties (excluding properties within our outpatient medical and research portfolio reportable business segment) to various healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures. Our three largest tenants, Brookdale Senior Living Inc. (together with its subsidiaries, “Brookdale Senior Living”), Ardent Health Partners, LLC (together with its subsidiaries, “Ardent”) and Kindred Healthcare, LLC (together with its subsidiaries, “Kindred”) leased from us 121 properties, 30 properties (including 19 outpatient medical buildings) and 29 properties, respectively, as of September 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, pursuant to long-term management agreements, we engaged operators, such as Atria Senior Living, Inc. (together with its subsidiaries, including Holiday Retirement (“Holiday”), “Atria”) and Sunrise Senior Living, LLC (together with its subsidiaries, “Sunrise”), to manage 594 senior housing communities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, we owned or had investments in a total of 461 properties in our outpatient medical and research portfolio reportable business segment. These properties generally consist of outpatient medical buildings that are predominantly located on or contiguous to a health system campus and research properties that are affiliated with and often located on or contiguous to a university or academic medical campus. Through our Lillibridge Healthcare Services, Inc. subsidiary and our ownership interest in PMB Real Estate Services LLC, we also provide outpatient medical building management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we make secured and unsecured loans and other investments relating to healthcare real estate or operators. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a third-party institutional capital management business, Ventas Investment Management (“VIM”), which includes our open-ended investment vehicle, the Ventas Life Science &amp; Healthcare Real Estate Fund (the “Ventas Fund”). Through VIM, we partner with third-party institutional investors to invest in healthcare real estate through various joint ventures and other co-investment vehicles where we are the sponsor or general partner.</span></div>
CY2023Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
1400 property
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q3 vtr Concentration Risk Number Of Tenants
ConcentrationRiskNumberOfTenants
3 tenant
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q3 us-gaap Real Estate Investments
RealEstateInvestments
579172000 usd
CY2022Q4 us-gaap Real Estate Investments
RealEstateInvestments
579949000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
50100000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
33500000 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
43191000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
5098000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
44893000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
6492000 usd
CY2023Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
72700000 usd
CY2022Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
28100000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
92000000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
55000000 usd
CY2023Q3 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities
52400000 usd
CY2022Q4 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities
561400000 usd
CY2023Q3 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost
56835000 usd
CY2023Q3 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
4425000 usd
CY2023Q3 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities
52410000 usd
CY2023Q3 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue
51249000 usd
CY2022Q4 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost
586034000 usd
CY2022Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
24621000 usd
CY2022Q4 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue
560449000 usd
vtr Gain Loss From Real Estate Operations Foreclosure
GainLossFromRealEstateOperationsForeclosure
29100000 usd
CY2023Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
33500000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1044536000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1044415000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1163233000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1061305000 usd
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1385701000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P7Y6M
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1363704000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P7Y9M18D
CY2023Q3 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
330143000 usd
vtr Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod
P8Y
CY2022Q4 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
333672000 usd
CY2022 vtr Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod
P8Y7M6D
CY2023Q3 vtr Other Finite Lived Intangible Liabilities Gross
OtherFiniteLivedIntangibleLiabilitiesGross
13498000 usd
CY2022Q4 vtr Other Finite Lived Intangible Liabilities Gross
OtherFiniteLivedIntangibleLiabilitiesGross
13498000 usd
CY2023Q3 vtr Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
259958000 usd
CY2022Q4 vtr Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
258639000 usd
CY2023Q3 vtr Indefinite Lived Intangible Liabilities Purchase Options
IndefiniteLivedIntangibleLiabilitiesPurchaseOptions
3568000 usd
CY2022Q4 vtr Indefinite Lived Intangible Liabilities Purchase Options
IndefiniteLivedIntangibleLiabilitiesPurchaseOptions
3568000 usd
CY2023Q3 vtr Finite And Indefinite Lived Intangible Liabilities Net
FiniteAndIndefiniteLivedIntangibleLiabilitiesNet
87251000 usd
vtr Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod
P8Y
CY2022Q4 vtr Finite And Indefinite Lived Intangible Liabilities Net
FiniteAndIndefiniteLivedIntangibleLiabilitiesNet
92099000 usd
CY2022 vtr Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod
P8Y7M6D
CY2023Q3 vtr Deferred Rent Receivable
DeferredRentReceivable
192137000 usd
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
187536000 usd
CY2023Q3 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
112194000 usd
CY2022Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
101185000 usd
CY2023Q3 vtr Non Mortgage Loans Receivable Net
NonMortgageLoansReceivableNet
24587000 usd
CY2022Q4 vtr Non Mortgage Loans Receivable Net
NonMortgageLoansReceivableNet
24338000 usd
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5774000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6393000 usd
CY2023Q3 vtr Investment In Unconsolidated Operating Entities
InvestmentInUnconsolidatedOperatingEntities
80039000 usd
CY2022Q4 vtr Investment In Unconsolidated Operating Entities
InvestmentInUnconsolidatedOperatingEntities
95363000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
234558000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
171387000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
684195000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
609823000 usd
CY2023Q3 us-gaap Commercial Paper
CommercialPaper
0 usd
CY2022Q4 us-gaap Commercial Paper
CommercialPaper
403000000 usd
CY2023Q3 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
13479362000 usd
CY2022Q4 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
12361244000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
87172000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
63410000 usd
CY2023Q3 vtr Debt Instrument Unamortized Fair Value Adjustment
DebtInstrumentUnamortizedFairValueAdjustment
17547000 usd
CY2022Q4 vtr Debt Instrument Unamortized Fair Value Adjustment
DebtInstrumentUnamortizedFairValueAdjustment
23535000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
21239000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
24589000 usd
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
13388498000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
12296780000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
15000000 usd
CY2023Q3 vtr Commercial Paper Program Capacity
CommercialPaperProgramCapacity
1000000000 usd
CY2023Q3 us-gaap Commercial Paper
CommercialPaper
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
83765000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1275712000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2140460000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1950050000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1581002000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
6448373000 usd
CY2023Q3 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
13479362000 usd
CY2023Q3 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
13479362000 usd
CY2022Q4 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
12361244000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1566000000 usd
vtr Loans Receivable Real Estate Received Capital Improvements
LoansReceivableRealEstateReceivedCapitalImprovements
31800000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-69559000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3063000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
54419000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2453000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14300000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26100000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35600000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7200000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10500000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-57252000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-60364000 usd
CY2023Q3 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
51070000 usd
CY2022Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
23564000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6182000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36800000 usd
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
11000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
327000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
381000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
268000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
390000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3469000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3516000 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3474000 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3517000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
406655000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
403543000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
405166000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
403431000 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.14
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
vtr Intersegment Sales And Transfers
IntersegmentSalesAndTransfers
0 usd
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
386138000 usd
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1208000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
2754000 usd
CY2023Q3 us-gaap Revenues
Revenues
1149832000 usd
CY2023Q3 us-gaap Revenues
Revenues
1149832000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
2754000 usd
CY2023Q3 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
656477000 usd
CY2023Q3 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1472000 usd
CY2023Q3 vtr Net Operating Income
NetOperatingIncome
489129000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
2754000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
147919000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
370377000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33297000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-612000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7125000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-66000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9432000 usd
CY2023Q3 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
-5119000 usd
CY2023Q3 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
10711000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1662000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-69559000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-69559000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1565000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-71124000 usd
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
350982000 usd
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
12672000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
489000 usd
CY2022Q3 us-gaap Revenues
Revenues
1037276000 usd
CY2022Q3 us-gaap Revenues
Revenues
1037276000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
489000 usd
CY2022Q3 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
569826000 usd
CY2022Q3 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1750000 usd
CY2022Q3 vtr Net Operating Income
NetOperatingIncome
465211000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
489000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
119413000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
301481000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35421000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-574000 usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4782000 usd
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-63000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9162000 usd
CY2022Q3 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
1970000 usd
CY2022Q3 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
136000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6027000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3063000 usd
vtr Gain Loss From Real Estate Operations Foreclosure
GainLossFromRealEstateOperationsForeclosure
29127000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
54419000 usd
us-gaap Profit Loss
ProfitLoss
54419000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4573000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49846000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1051721000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
33271000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
2191000 usd
us-gaap Revenues
Revenues
3077768000 usd
us-gaap Revenues
Revenues
3077768000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
2191000 usd
us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
1686906000 usd
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
4473000 usd
vtr Net Operating Income
NetOperatingIncome
1384198000 usd
us-gaap Interest Expense
InterestExpense
344158000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
873620000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
111334000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-581000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
37852000 usd
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-179000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2453000 usd
us-gaap Profit Loss
ProfitLoss
2453000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4881000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2428000 usd
CY2023Q3 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
162576000 usd
CY2022Q3 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
159871000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
404633000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
721048000 usd
CY2023Q3 us-gaap Revenues
Revenues
1149832000 usd
CY2022Q3 us-gaap Revenues
Revenues
1037276000 usd
us-gaap Revenues
Revenues
3333435000 usd
us-gaap Revenues
Revenues
3077768000 usd
CY2023Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
22088781000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
21160450000 usd

Files In Submission

Name View Source Status
0000740260-23-000188-index-headers.html Edgar Link pending
0000740260-23-000188-index.html Edgar Link pending
0000740260-23-000188.txt Edgar Link pending
0000740260-23-000188-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtr-20230930.htm Edgar Link pending
vtr-20230930.xsd Edgar Link pending
vtr-ex22_093023.htm Edgar Link pending
vtr-ex311_093023.htm Edgar Link pending
vtr-ex312_093023.htm Edgar Link pending
vtr-ex321_093023.htm Edgar Link pending
vtr-ex322_093023.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
vtr-20230930_cal.xml Edgar Link unprocessable
vtr-20230930_def.xml Edgar Link unprocessable
vtr-20230930_lab.xml Edgar Link unprocessable
vtr-20230930_pre.xml Edgar Link unprocessable
vtr-20230930_htm.xml Edgar Link completed